Lindsay A. Rosenwald
2023
In 2023, Lindsay A. Rosenwald earned a total compensation of $1.1M as Chairman, President and Chief Executive Officer at Fortress Biotech, a 11% decrease compared to previous year.
Compensation breakdown
| Option Awards | $104,000 |
|---|---|
| Salary | $62,665 |
| Stock Awards | $805,920 |
| Other | $150,000 |
| Total | $1,122,585 |
Rosenwald received $805.9K in stock awards, accounting for 72% of the total pay in 2023.
Rosenwald also received $104K in option awards, $62.7K in salary and $150K in other compensation.
Rankings
In 2023, Lindsay A. Rosenwald's compensation ranked 946th out of 2,179 executives tracked by ExecPay. In other words, Rosenwald earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 946 out of 2,179 | 57th |
Division Manufacturing | 553 out of 1,176 | 53rd |
Major group Chemicals And Allied Products | 374 out of 659 | 43rd |
Industry group Drugs | 364 out of 630 | 42nd |
Industry Pharmaceutical Preparations | 254 out of 457 | 44th |
Source: SEC filing on April 5, 2024.
Rosenwald's colleagues
We found two more compensation records of executives who worked with Lindsay A. Rosenwald at Fortress Biotech in 2023.